253 related articles for article (PubMed ID: 34590140)
1. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
Gershon AA; Gershon MD; Shapiro ED
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S387-S397. PubMed ID: 34590140
[TBL] [Abstract][Full Text] [Related]
2. Varicella Virus Vaccination in the United States.
Shaw J; Gershon AA
Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
[TBL] [Abstract][Full Text] [Related]
3. Perspective on live varicella vaccine.
Gershon AA; Katz SL
J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
[TBL] [Abstract][Full Text] [Related]
4. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
[TBL] [Abstract][Full Text] [Related]
5. Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?
Gershon AA
J Infect; 2017 Jun; 74 Suppl 1(Suppl 1):S27-S33. PubMed ID: 28646959
[TBL] [Abstract][Full Text] [Related]
6. Universal varicella vaccine immunization in Japan.
Yoshikawa T; Kawamura Y; Ohashi M
Vaccine; 2016 Apr; 34(16):1965-70. PubMed ID: 26944711
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
Wolff E; Widgren K; Scalia Tomba G; Roth A; Lep T; Andersson S
PLoS One; 2021; 16(5):e0251644. PubMed ID: 33984060
[TBL] [Abstract][Full Text] [Related]
8. [Varicella vaccination: who should be vaccinated these days?].
Hügle B; Suchowerskyj P; Schuster V
MMW Fortschr Med; 2005 Feb; 147(8):31-2, 34-5. PubMed ID: 18441563
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated varicella vaccine.
Arvin AM; Gershon AA
Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
[TBL] [Abstract][Full Text] [Related]
12. Strategies for herpes zoster vaccination of immunocompromised patients.
Cohen JI
J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S237-41. PubMed ID: 18419403
[TBL] [Abstract][Full Text] [Related]
13. Molecular studies of the Oka varicella vaccine.
Quinlivan M; Breuer J; Schmid DS
Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
[TBL] [Abstract][Full Text] [Related]
14. The current status of live attenuated varicella vaccine.
Gershon AA
Arch Virol Suppl; 2001; (17):1-6. PubMed ID: 11339539
[TBL] [Abstract][Full Text] [Related]
15. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
Goldman GS; King PG
Hum Exp Toxicol; 2014 Aug; 33(8):886-93. PubMed ID: 24275643
[TBL] [Abstract][Full Text] [Related]
16. [Immunization of adults against varicella and herpes zoster].
Hanslik T; Blanchon T; Alvarez FP
Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
[TBL] [Abstract][Full Text] [Related]
17. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults.
Hendriksz T; Malouf P; Foy JE;
J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S10-2. PubMed ID: 22086887
[TBL] [Abstract][Full Text] [Related]
19. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
20. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]